全文获取类型
收费全文 | 8382篇 |
免费 | 800篇 |
国内免费 | 38篇 |
专业分类
耳鼻咽喉 | 59篇 |
儿科学 | 266篇 |
妇产科学 | 151篇 |
基础医学 | 1157篇 |
口腔科学 | 198篇 |
临床医学 | 1014篇 |
内科学 | 1713篇 |
皮肤病学 | 103篇 |
神经病学 | 606篇 |
特种医学 | 280篇 |
外科学 | 1363篇 |
综合类 | 244篇 |
一般理论 | 9篇 |
预防医学 | 871篇 |
眼科学 | 101篇 |
药学 | 562篇 |
肿瘤学 | 523篇 |
出版年
2021年 | 91篇 |
2020年 | 66篇 |
2019年 | 103篇 |
2018年 | 139篇 |
2017年 | 84篇 |
2016年 | 86篇 |
2015年 | 107篇 |
2014年 | 157篇 |
2013年 | 260篇 |
2012年 | 362篇 |
2011年 | 368篇 |
2010年 | 189篇 |
2009年 | 200篇 |
2008年 | 375篇 |
2007年 | 394篇 |
2006年 | 413篇 |
2005年 | 368篇 |
2004年 | 356篇 |
2003年 | 312篇 |
2002年 | 342篇 |
2001年 | 297篇 |
2000年 | 277篇 |
1999年 | 228篇 |
1998年 | 130篇 |
1997年 | 119篇 |
1996年 | 105篇 |
1995年 | 95篇 |
1994年 | 76篇 |
1993年 | 107篇 |
1992年 | 200篇 |
1991年 | 174篇 |
1990年 | 207篇 |
1989年 | 176篇 |
1988年 | 158篇 |
1987年 | 156篇 |
1986年 | 141篇 |
1985年 | 160篇 |
1984年 | 124篇 |
1983年 | 89篇 |
1982年 | 67篇 |
1981年 | 68篇 |
1979年 | 115篇 |
1978年 | 85篇 |
1976年 | 72篇 |
1975年 | 76篇 |
1974年 | 86篇 |
1973年 | 82篇 |
1972年 | 87篇 |
1970年 | 67篇 |
1969年 | 81篇 |
排序方式: 共有9220条查询结果,搜索用时 15 毫秒
81.
BACKGROUND/AIMS: Many tumor markers have been utilized in the follow-up care of colorectal cancer patients. No marker, however, has proven reliably accurate in detecting recurrent disease. METHODS: The strengths and weaknesses of currently available tumor markers are reviewed, with attention to related cost and efficacy. RESULTS: Tumor antigens, enzymes, and genetic markers have been used as tumor markers. CEA and CA 19.9 are the most widely utilized; however, genetic markers are the most promising for the future. CONCLUSIONS: Currently available markers have significant limitations. Development of genetic markers may greatly enhance our ability to predict prognosis and the need for adjuvant therapy. Marker-guided therapy may play an increasing role in this disease. 相似文献
82.
Baumgartner KB Samet JM Coultas DB Stidley CA Hunt WC Colby TV Waldron JA 《American journal of epidemiology》2000,152(4):307-315
Occupational exposures were investigated in a multicenter case-control study of clinically and histologically diagnosed idiopathic pulmonary fibrosis (IPF), a chronic diffuse interstitial lung disease of unknown etiology. Results are based on 248 cases, aged 20-75 years, diagnosed at 16 referral centers between January 1989 and July 1993. There were 491 controls ascertained by random digit dialing and matched to cases on sex, age, and geographic region. Data were collected using a standard telephone questionnaire. Occupational factors were based on a detailed history of jobs lasting 6 months or more and job activity, hobby, and specific substance checklists. Several occupational factors, adjusted for age and smoking in conditional multivariate logistic regression analyses, were significantly associated with IPF: farming (odds ratio (OR) = 1.6, 95% confidence interval (CI): 1.0, 2.5); livestock (OR = 2.7, 95% CI: 1.3, 5.5); hairdressing (OR = 4.4, 95% CI: 1.2, 16.3); metal dust (OR = 2.0, 95% CI: 1.0, 4.0); raising birds (OR = 4.7, 95% CI: 1.6, 14.1); stone cutting/polishing (OR = 3.9, 95% CI: 1.2, 12.7); and vegetable dust/animal dust (OR = 4.7, 95% CI: 2.1, 10.4). Interaction was detected between smoking and exposure to livestock (p = 0.06) and farming (p = 0.08). Results confirm previous studies showing increased risk associated with dusty environments. 相似文献
83.
84.
85.
Analysis of pulmonary fat embolism in blunt force fatalities 总被引:14,自引:0,他引:14
Mudd KL Hunt A Matherly RC Goldsmith LJ Campbell FR Nichols GR Rink RD 《The Journal of trauma》2000,48(4):711-715
OBJECTIVE: To investigate the incidence, severity, and origin of pulmonary fat embolism (PFE) in persons dying from blunt force trauma within 24 hours of injury. METHODS: The study population consisted of blunt force fatalities. Controls were subjects dying from natural causes or nonblunt force injury. Tissue was removed from lung lobes and prepared for histologic examination using osmium tetroxide to stain for fat. Lung sections were graded for PFE on a scale of 0 (no emboli) to 4 (five or more emboli in a majority of fields). RESULTS: The blunt force group consisted of 56 decedents. Mortality was 93% within 4 hours. Fractures were present in 54 (96%) of decedents, and soft tissue injury was universal. Thirty eight (68%) of decedents were positive for PFE vs. 3 of 20 (15%) in controls. Mean score for PFE was 2.94 +/- 1.15 and 1.01 +/- 0.94, respectively (p < 0.005). Bone marrow emboli were not observed in any of the sections. Severity of PFE was positively associated with survival time. Analysis of PFE against sex, age, height, weight, number of injuries, and number of fractures showed no significant correlations. CONCLUSIONS: A significant degree of PFE develops rapidly in a majority of persons dying of blunt force trauma. Although the source of fat for embolization has been suggested to be bone marrow, no evidence of myeloid tissue was found in any of the lung sections. Nor was there a correlation of PFE and number of fractures. Soft tissue injury is considered the primary cause of PFE. 相似文献
86.
Hunt LE Eichenberger MR Petras R Galandiuk S 《Archives of surgery (Chicago, Ill. : 1960)》2000,135(5):582-585
BACKGROUND: Patients with ulcerative colitis (UC) have an increased risk of developing colorectal cancer. The current screening protocol involves an annual colonoscopy and biopsy after the patient has had the disease for 8 years. This, however, does not prevent the development of colorectal cancer. HYPOTHESIS: A microsatellite marker for IBD1 may identify individuals who are at greater risk of developing dysplasia and therefore colorectal cancer. DESIGN: Case-control study. SETTING: Single surgical practice. PATIENTS AND METHODS: DNA was extracted from peripheral leukocytes of 152 patients: 22 with UC and dysplasia; 48 with UC and no dysplasia; 24 with colorectal cancer; and 58 with noninflammatory bowel disease, nonmalignant gastrointestinal tract disease who were used as control patients. A microsatellite marker for IBD1 (D16S541) was amplified by polymerase chain reaction. Genotypes were identified using autoradiography. RESULTS: Six alleles and 15 genotypes were identified for marker D 16S541. Genotype CC was found in 33% (8/24) of cancer patients but only 12% (7/58) of controls (chi2 = 5.5; P = .02). Thirty-two percent (7/22) of patients with dysplastic UC also had this genotype, whereas only 8% (4/ 48) of patients with nondysplastic UC had the genotype (chi2 = 4.6; P = .03; vs controls: chi2 = 3.1; P = .08). CONCLUSIONS: This microsatellite marker for IBD1, when combined with other markers, has the potential to be used as a screening tool for colorectal cancer and dysplasia in patients with UC. Such a marker would be of particular use in improving the sensitivity and specificity of the current screening protocol for dysplasia and colorectal cancer for patients with UC. 相似文献
87.
88.
Several studies have demonstrated that uterine cells are capable of suppressing in vitro immune responses in a nonspecific manner. Two types of cells have been implicated as responsible for suppression, cells with the features of macrophages and a small lymphocyte-like cell. In the present study the maternal anti-paternal mixed lymphocyte reaction was used to investigate further the characteristics of uterine suppressor cells. Three distinct suppressor cell populations were identified: highly suppressive macrophages, small lymphocyte-like cells, and a morphologically heterogeneous third population of highly suppressive cells. The data from this study suggest that pregnant murine uteri contain a variety of cells capable of discouraging lymphocyte proliferation in vitro. 相似文献
89.
vom Saal FS Akingbemi BT Belcher SM Birnbaum LS Crain DA Eriksen M Farabollini F Guillette LJ Hauser R Heindel JJ Ho SM Hunt PA Iguchi T Jobling S Kanno J Keri RA Knudsen KE Laufer H LeBlanc GA Marcus M McLachlan JA Myers JP Nadal A Newbold RR Olea N Prins GS Richter CA Rubin BS Sonnenschein C Soto AM Talsness CE Vandenbergh JG Vandenberg LN Walser-Kuntz DR Watson CS Welshons WV Wetherill Y Zoeller RT 《Reproductive toxicology (Elmsford, N.Y.)》2007,24(2):131-138
90.
Alfio Ferlito Alessandra Rinaldo Justin A. Bishop Jennifer L. Hunt Vincent Vander Poorten Michelle D. Williams Asterios Triantafyllou Kenneth O. Devaney Douglas R. Gnepp Kimihide Kusafuka Gyorgy B. Halmos William H. Westra Robert P. Takes Lester D. R. Thompson 《European archives of oto-rhino-laryngology》2016,273(3):533-536
Paraneoplastic syndromes are associated with a variety of malignant neoplasms and are systemic and non-metastatic manifestations that develop in a minority of cancer patients. This review examines all published cases of paraneoplastic syndromes associated with neuroendocrine carcinomas of the larynx. There are a total of ten patients reported with paraneoplastic syndromes associated with laryngeal neuroendocrine carcinomas in the literature. Of these, nine died and the tenth is alive with liver metastases. There were five cases of small-cell neuroendocrine carcinoma, four cases of moderately differentiated neuroendocrine carcinoma, and one case of well-differentiated neuroendocrine carcinoma associated with paraneoplastic syndromes. As these syndromes have significant clinical relevance, physicians should be aware of the possible presence of paraneoplastic syndromes in the diagnostic process of patients with neuroendocrine carcinoma of the larynx. 相似文献